Profilaktyka i leczenie powikłań sercowo-naczyniowych u chorych na przewlekłą niewydolność nerek

Krzysztof Pawlaczyk

ISSN: 1505-8409

Przewodnik Lekarza/Guide for GPs

Current issue Archive About the journal Supplements Abstracting and indexing Contact Instructions for authors

5/2009
vol. 12

Send email

Copy url:

abstract:

Profilaktyka i leczenie powikłań sercowo-naczyniowych u chorych na przewlekłą niewydolność nerek

Krzysztof Pawlaczyk

Przew Lek 2009; 5: 47-50

Online publish date: 2009/10/05

View full text Get citation

Cardiovascular disease (CVD) is the major cause of death in renal failure. Available data demonstrate that chronic inflammation, a non-traditional risk factor which is observed commonly in uremic patients, play a key role in the genesis of CVD in ESRD. Additionally, inflammation is associated with congestive heart failure. There is evidence that a chronic inflammation with activation of C-reactive protein, interleukin-6, tumour necrosis factor alpha and other pro-inflammatory cytokines is associated with increased oxidative stress and endothelial dysfunction in ESRD patients. Strong relations between inflammation, oxidative stress and atherosclerosis in ESRD patients suggest that suppression of the vicious cycle of inflammation and atherosclerosis (MIA) would improve survival in ESRD patients. Therefore, the early stage of chronic renal failure is the perfect time to start therapeutic interventions and especially to protect against development of cardiovascular risk factors.

keywords:

Profilaktyka i leczenie powikłań sercowo-naczyniowych u chorych na przewlekłą niewydolność nerek

Krzysztof Pawlaczyk

cardiovascular disease, chronic renal failure, inflammation